EP07.01. Can the Use of New Haemostatic Agent Improve Short Term Outcomes of Surgically Treated Non-small Cell Lung Cancer Patients? - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Sara Ricciardi
Meta Tag
Speaker Sara Ricciardi
Topic Early-Stage NSCLC: Best Practice
haemostatic agent
Microporous Polysaccharide Hemospheres
short-term outcomes
surgically treated
non-small cell lung cancer
retrospective review
early-stage lung cancer
univariate analysis
linear regression models
Powered By